The Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory is a cornerstone of our research program, the first at UCLA to be solely dedicated to investigating the driving forces and […]
Seed Grant Research Update: Biomarkers for Early Detection
The Hirshberg Foundation’s Seed Grant Program remains instrumental in funding pancreatic cancer research worldwide, spanning many critical areas. Although pancreatic cancer is difficult to detect early, the Foundation is committed […]
The 2023 APA Meeting highlights the impact of AI in pancreatic cancer research
The partnership between The Hirshberg Foundation and the American Pancreatic Association (APA) continues to unite brilliant minds, showcases significant topics and keynote speakers, and highlights the contributions of researchers through […]
Updates from our UCLA Seed Grant Recipients
In early October, we hosted a gathering of scientists and researchers working on pancreatic cancer at UCLA, highlighting some of our recent Seed Grant awardees. With the goal to share […]
UCLA Joins the Pancreatic Cancer Early Detection (PRECEDE) Consortium to Transform Early Detection and Survival Rates
Dr. Timothy Donahue, Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases and Garry Shandling Chair in Pancreatic Surgery at David Geffen School of Medicine at UCLA, has joined […]
An Overview of the Updates to the NCCN Guidelines for Pancreatic Cancer
The National Comprehensive Cancer Network (NCCN) works to improve cancer care through their vast collection of Guidelines for Patients. The latest version of the Guidelines for Patients: Pancreatic Cancer, sponsored […]